This makes it significantly more practical than single-use sterile water for research protocols that involve repeated compound preparation over days or weeks
Afamelanotide (MT-1) was approved by the EMA in 2014 and FDA in 2019 under the brand name Scenesse for erythropoietic protoporphyria
Synthetic peptides in the unregulated space capture a unique tension in health and wellness
Schumacher, B., Pothof, J., Vijg, J
Water, Myristic Acid, Glycerin, Potassium Hydroxide, Palmitic Acid, Lauric Acid, Butylene Glycol, Benzyl Glycol, Salicylic Acid, Glyceryl Stearate, 1,2-Hexanediol, Mentha Piperita (Peppermint) Oil, Hydroxyethylcellulose, Ethyl Hexanediol, Centella Asiatica Extract, Ethylhexylglycerin, Asiaticoside, Madecassic Acid, Asiatic Acid, Dipotassium Glycyrrhizate, Melaleuca Alternifolia (Tea Tree) Leaf Water, Madecassoside, Gluconolactone, Citric Acid, Sodium Methyl Cocoyl Taurate, Lauryl Betaine, Coco-Betaine, Polysorbate 60, Disodium Phosphate, Sodium Chloride, Artemisia Vulgaris Extract, Calamine, Sodium Phosphate